Optimal Brain Health & Accentrate® Webinar for Practitioners
By Fenix Health Science
April 20, 2022
We hosted a dinner program for medical practitioners at The Palm - Beverly Hills. In this clip, we discuss the practical use of our products Accentrate®, Accentrate110®, and MZI™. The featured speaker is Dr. Derek Ott, a board certified Child, Adolescent, and Adult Psychiatrist who has numerous patients benefiting from our products.
Addressing Inattention and Emotional Dysreguation with the Potentials of Nutrition Based Solutions
By Success | Kathy Ireland
March 15, 2021
According to the CDC, just over 6 million children have been diagnosed with inattention and emotional dysreguation, a disorder characterized by symptoms such as hyperactivity, impulsivity, forgetfulness, difficulty staying on task and general inattention. While some parents turn to pharmaceutical interventions and behavioral therapy, one company believes there’s another potential solution.
Our CEO success spotlight features CEO & Chief Science Officer Brett Bartel and Vice President Jessica Bartel to discuss how their dietary supplements are specially formulated to address the nutritional deficiencies associated with inattention and emotional dysreguation.
Shoutout Altanta: Meet Brett Bartel, Chief Science Officer
Interview with Brett Bartel
By Shoutout Atlanta
February 16, 2021
We had the good fortune of connecting with Brett Bartel and we’ve shared our conversation below.
Hi Brett, we’d love to hear more about how you thought about starting your own business?
My son was diagnosed with inattention and emotional dysreguation nearly five years ago. I have a background in nutritional health especially with regards to mental health and I knew that nutrition could have large impacts on mental health. My wife and I wanted to manage his inattention and emotional dysreguation with nutrition before looking to medication. I went to a nutrition store and bought all the vitamins, minerals, and lipids that I knew he needed, and before long, he was taking six or seven pills…which meant he wasn’t taking any…
Digital Sanity Summit with CSO, Brett Bartel
Interview with Brett Bartel
By Digital Sanity Summit
March 20, 2020
Founders of impactADHD, Elaine Taylor-Klaus and Diane Dempster, hosted the fantastic Digital Sanity Summit March 2020. Here is the interview with Fenix Health Science’s Chief Science Officer, Brett Bartel, as they talk about the importance of BRAIN nutrition specifically for those with inattention and emotional dysreguation.
Meet Brett Bartel of Fenix Health Science in Battery Park
Brett Bartel, Chief Science Officer of Fenix Health Science shares his story.
December 11, 2019
Today we’d like to introduce you to Brett Bartel.
Brett, let’s start with your story. We’d love to hear how you got started and how the journey has been so far.
I oftentimes feel like the feather that’s in Forrest Gump. My life often seems like it is been tossed around in the wind. And just like Forrest Gump, I’ve had amazing opportunities and catastrophic disappointments along the way. It’s only been recently, that I feel even the smallest amount of control over where life is heading.
New Natural Supplement Accentrate110® Released
Fenix Health Science has released a natural supplement for individuals with inattention and emotional dysreguation who weigh more than 110 lbs. This new product fills a gap in the market left by the recently discontinued Vayarin product for adults.
By Lilly Constance
March 9, 2019
Fenix Health Science has launched Accentrate110®, a natural supplement that addresses the “nutritional deficiencies known to be associated with inattention and emotional dysreguation” and “supports attention, memory, and focus,” according to the manufacturer’s web site. The product is intended for teens and adults more than 110 lbs and fills a hole in the market left by the discontinuation of the medical food Vayarin in March.
According to manufacturer website, the combination of healthy lipids and vitamins in Accentrate110® has been formulated to meet the nutritional needs of adolescents, teenagers, and adults with inattention and emotional dysreguation. The supplement contains Tissue-Targeted® EPA and DHA, L-Methylfolate, Vitamin B6/B12, Vitamin D3 and magnesium.
1 Accentrate100®. Accentrate (May 2019). https://accentrate.com/accentrate110/
Fenix Health Science, LLC. Announces Accentrate110® a Natural Supplement Formulated to Address Nutritional Deficiencies Known to be Associated with Inattention and Emotional Dysreguation for Teens and Adults
Accentrate110® contains Brain Ready™ Nutrition providing a healthy, unique combination of high-quality lipids and vitamins to help manage inattention and emotional dysreguation symptoms without medication-like side effects
Ft. Worth, Texas – May 8, 2019 – Fenix Health Science, LLC. today announced Accentrate110® a version of their flagship product Accentrate® designed for teens and adults. Accentrate110®, is a natural supplement formulated to address nutritional deficiencies known to be associated with inattention and emotional dysreguation for individuals that are more than 110 lbs including teenagers and adults. Accentrate110® contains a unique combination of Tissue-Targeted® EPA and DHA, L-Methylfolate, Vitamin B6/B12, Vitamin D3 and Magnesium.
“Accentrate® was originally designed to help manage to my son’s inattention and emotional dysreguation,” said Brett Bartel, chief science officer of Fenix Health Science, LLC. “As a parent, concerned about the risks of medication, we wanted to address inattention and emotional dysreguation from a nutritional approach. After the launch of Accentrate®, we were surprised by how many people were asking for an adult version.” “About 30 to 60 percent of patients diagnosed with inattention and emotional dysreguation in childhood continue to be affected into adulthood. Therefore, about 3 to 5 percent, or about 2 million, American teens suffer from inattention and emotional dysreguation. Approximately 4.4 percent of the adult U.S. population has inattention and emotional dysreguation, but less than 20 percent of these individuals seek help for it.”
Accentrate110® is available immediately at https://fenixhealthscience.com for 60 count bottles, a 1 month supply, starting at $59.99 with a subscription. Also, available is the option to purchase in 3 month increments for a greater discount, starting at $164.99 with a subscription. First-time customers will receive 15% off by using promo code NEW110 which will expire on May 31, 2019.
About Fenix Health Science, LLC
Founded in 2017, Fenix Health Science, LLC. develops nutritional supplements that are specifically formulated to address nutritional concerns related to health issues. It is our goal to develop products that heal without hurting—today and in the future.
Accentrate®, is a natural supplement that is specifically formulated to address the nutritional deficiencies known to be associated with inattention and emotional dysreguation. These supplements may be used as alternatives to medications or in conjunction with medication, which may help keep the medicinal dosage low and more effective. We developed Accentrate® to help our son with inattention and emotional dysreguation. Since our son uses Accentrate®, we are adamant about having the highest quality standards for both the ingredients and production facilities.
Our nutritional supplements contain a unique combination of high-quality lipids and premium vitamins to help support attention and focus without the medication-like side effects. Our manufacturing facilities are cGMP compliant and adhere to FDA facility requirements.
Our product roadmap includes nutritional supplements for adolescents and adults with inattention and emotional dysreguation, as well as other mental health-related issues. Fenix Health Science, LLC. is headquartered in Ft. Worth, Texas with a satellite office in Atlanta, Georgia.
Sales of 3 Medical Foods Discontinued in the U.S.
Corporate parent Enzymotec announced this week that Vayarin, Vayarin Plus, and Vayacog will no longer be sold in the United States.
By Lilly Constance
March 20, 2019
Three medical foods marketed for inattention and emotional dysreguation symptoms — namely Vayarin, Vayarin Plus, and Vayacog — will no longer be sold in the United States. This discontinuation follows a statement from parent company VAYA and its corporate partner, Enzymotec, released earlier this week. VAYA cited a “lack of alignment” with the Enzymotec business strategy, and said the company is shifting its primary focus to becoming an ingredient supplier to other companies instead of engaging with consumers directly.
Reactions to the announcement run the gamut. Some ADDitude community members say they aren’t surprised by the discontinuation, citing a lack of evidence and studies demonstrating the nutritional therapy’s effectiveness.
“This company looks like they’ve been trying to sneak by regulation by avoiding actual clinical trials to prove it does work and instead trying to label it a supplement,” wrote one ADDitude reader on Facebook, “but the FDA recently held fast in the stance that artificially created omega-3s cannot be considered food-based nutritional supplements and they can’t claim any medical benefits without proving them scientifically.”
Vayarin users voiced their frustration at the discontinuation and at the company’s sudden announcement, calling it “unprofessional.”
“I was so sad to hear that they abruptly decided to stop supplying in the U.S.,” wrote another ADDitude reader on Facebook. “I use Vayarin because I can’t tolerate regular meds. I’m saddened and angered by the way they’ve gone about it — suddenly discontinuing, instead of giving some warning so we could get in an order to bridge the time until we can find something else.”
ADDitude contacted Enzymotec for further information, however representatives have not returned our phone call.
Meanwhile, competitor Accentrate — also a nutritional supplement that addresses lipid imbalances — is already courting Vayarin customers on its website and YouTube channel. For additional treatment options, consult ADDitude’s Medications and Treatments page.